was 77%, during which four patients died of nonaortic disease. Reintervention rate at 2 years was 24% (Fig). One patient had an open conversion for type IA endoleak, one patient has had continued aneurysmal growth during 6 years by non-contrast-enhanced imaging but has declined intervention, and one patient has a type IB leak but elected to complete a course of chemotherapy before repair. One patient had asymptomatic occlusion of the carotid stent.
IP067.
Outcomes of Surgeon-Modified Fenestrated Endografts in the Treatment of High-Risk and Acute Aortic Disease Objective: The application of surgeon-modified fenestrated endografts to high-risk and acute aortic disease is desirable because of the morbid nature of open repair; however, the feasibility of this is largely unknown. We sought to describe outcomes of surgeon-modified fenestrated endovascular aneurysm repair (sm-FEVAR) for acute and high-risk aortic disease in patients who were deemed poor surgical candidates.
Methods: We retrospectively queried institutional data for all patients treated with sm-FEVAR at our facility between 2009 and 2017. The sm-FEVAR was performed for clinical necessity, with the patient's consent, and in anticipation of a physician-sponsored investigational device exemption application (Q171179). Predictors of major complications were determined using either c 2 test or t-test. Survival, reinterventionfree survival, and branch patency were analyzed using the Kaplan-Meier methods.
Results: Thirty-seven patients (mean age, 72.0 6 8.0 years; 67.2% male; follow-up, 319 6 420 days) underwent sm-FEVAR for paravisceral aneurysm (n ¼ 13), thoracic aortic aneurysm (n ¼ 9), anastomotic pseudoaneurysm (n ¼ 7), type IA endoleak, status post EVAR (n ¼ 5), and chronic type B aortic dissection (n ¼ 3). Average maximum diameter was 67.5 6 21.0 mm. Fifteen patients (40.5%) were symptomatic; one patient was ruptured. There were 104 branches total (mean, 2.8 6 1.2; celiac, 22; superior mesenteric artery, 32; renal, 50). Major complications occurred in 32% of patients (30-day mortality, 10.8%; spinal cord ischemia, 18.9%; newonset dialysis, 8.1%; respiratory failure, 13.5%). Repair for thoracic aortic aneurysm was associated with spinal cord ischemia (odds ratio, 11.1; 95% confidence interval [CI], 1.49-82.4; P ¼ .01) and major complications (odds ratio, 5.54; 95% CI, 1.81-16.95; P < .01). One-year survival, reintervention-free survival, and branch patency were 88.6% (95% CI, 78.6%-99.8%), 59.0% (41.3%-84.3%), and 95.9% (90.3%-100%), respectively (Fig) . Endoleak was present in 39% of patients during follow-up.
Conclusions: In our early experience, perioperative morbidity for sm-FEVAR is significant; however, it is less than reported rates for open repair in such high-risk patients and can be used to treat a variety of aortic diseases. Further studies and experience are needed to improve perioperative outcomes, to reduce reinterventions, and to improve long-term durability. Methods: We performed a retrospective review of all patients who underwent FEVAR at our institution with the Zenith Fenestrated AAA Endovascular Graft (Cook Medical, Bloomington, Ind) from 2013 to 2018. Small, slow type I and type III endoleaks at the end of the index procedure were routinely observed. We identified patients with type I or type III endoleaks by review of the completion angiogram and subsequently characterized endoleak type and location.
Results: Of 49 patients who underwent FEVAR, 28 (57%) had evidence of a type I or type III endoleak after implantation of all devices. Eleven patients underwent further intervention at the index procedure, and three endoleaks resolved completely. Twenty-five patients (51%) had a type I or type III endoleak on completion angiography. We excluded three patients without postoperative imaging: two yet to complete initial postoperative computed tomography angiography or duplex ultrasound and one lost to follow-up after discharge. For the 22 remaining patients, mean age was 75.6 years; 77% were male, and 77% were white. Mean aneurysm diameter was 61 mm. There were 61 branch vessels (42 renal Author Disclosures: C. Li: Nothing to disclose; P. Liang: Nothing to disclose; T. F.X. O'Donnell: Nothing to disclose; M. L. Schermerhorn: Abbott: Consulting fees (eg, advisory boards), Bolton: Consulting fees (eg, advisory boards), Cook: Consulting fees (eg, advisory boards), Endologix: Consulting fees (eg, advisory boards); N. J. Swerdlow: Nothing to disclose. Methods: Consecutive patients undergoing elective FEVAR and OR of suprarenal and type IV TAAAs between January 2012 and November 2015 were included. Choice between FEVAR and OR was based on anatomic criteria and the patient's comorbidities. In the OR group, an extracorporeal circulation was systematically used to provide oxygenated isothermic blood to the renal and the visceral arteries during aortic clamping.
IP071.

Comparison of Fenestrated Endovascular and
Results: During the study period, 26 patients underwent FEVAR and 26 underwent OR. Patients in the FEVAR group were significantly older (FEVAR, 74 6 8 years; OR, 67 6 8 years; P < .001) and had a lower preoperative glomerular filtration rate (FEVAR, (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) (74) (75) (76) (77) (78) (79) (80) (81) Moderate to severe complication rates were 54% (14/26) in the FEVAR group and 65% (17/26; P ¼ .4) in the OR group. Permanent paraplegia occurred in one (4%) FEVAR patient and two (8%) OR patients. In the FEVAR group, two (8%) patients required permanent dialysis. In the OR group, four (15%) patients required transient dialysis. The mean followup time was 37 6 20 months after FEVAR and 35 6 18 months after OR. At 24 months, the actuarial survival rate was significantly higher in the OR group (FEVAR group, 62%; OR group, 92%; log-rank test, P ¼ .03), and estimated freedom from reintervention rates (FEVAR vs OR group, 64% vs 64%; log-rank test, P ¼ .63) were not significantly different between both groups.
Conclusions: In this study, no significant difference in terms of postoperative mortality, complication, and reintervention rates could be identified between FEVAR and OR for suprarenal and type IV TAAAs. OR provided good midterm results.
Author Disclosures: E. Allaire: Nothing to disclose; I. Ben Abdallah: Nothing to disclose; F. Cochennec: Nothing to disclose; P. Desgranges: Nothing to disclose; J. Sénémaud: Nothing to disclose; J. Touma: Nothing to disclose. Objective: Readmissions after acute type A aortic dissection (AAAD) are not well described. Characterization of causes and identification of predictors of readmission could result in improved outcomes. We evaluated our experience to determine the rate and to identify risk factors for readmission after open AAAD repair managed at our institution during a decade.
IP073. Predictors and Descriptors of Readmissions After Acute Aortic Dissection
Methods: Of the 435 patients who presented to our service between 2004 and 2014, there were 411 who underwent repair for AAAD. Of these, 357 survived the initial hospitalization and were evaluated for this analysis. Follow-up was performed through prospective phone contact and retrospective review of records under an Institutional Review Boardapproved protocol to obtain the cause, frequency, length of stay, management, and related characteristics for each reported readmission and emergency department visit. Data were analyzed by univariate and multivariable analysis.
Results: Of those who survived AAAD repair, 64 (16%) had readmissions within 30 days. The median interval between initial discharge and readmission was 7 (interquartile range, 3-21) days. The 30-day readmission rate was slightly more in women (23% vs 16%), younger patients (53 vs 57 years), and substance abusers (17% vs 7%; P < .008). The median readmission length of stay was 3 days (interquartile range, 1-12 days). Multivariable analysis identified age <60 years, female sex, coronary artery disease, substance abuse, and postoperative infection to be predictive of 30-day readmissions. During a median follow-up of 5 years, 204 (57%) patients were readmitted for various aortic (17%), cardiac (15%), neurologic (10%), hypertensive crisis (10%), and gastrointestinal (15%) reasons. Recurrent or persistent pain (21%) was one of the most significant predictors for multiple readmissions (P < .001) in addition to connective tissue disorder (odds ratio, 3.2; P < .016). Overall, 12% of patients required aortic reinterventions during a median of 2 years after initial AAAD repair. Of these, proximal aortic repair (redo or root) was performed in 22% of cases and distal thoracoabdominal aortic repair in 88% (36). Independent correlates of aortic event readmissions included age >70 years, connective tissue disorder, female sex, postoperative bleeding complications, low baseline glomerular filtration rate, and multiple readmissions. Long-term readmission-free and aortic event-free survival at 1 year and 5 years were 40% and 56% and 87% and 76%, respectively.
Conclusions: Readmission after repair of AAAD is common. Age <60 years, female sex, coronary artery disease, substance abuse, and postoperative infection were strong predictors of early readmissions. Recurrent (chest, back, abdominal) pain was significantly correlated with multiple readmissions and low event-free survival. Routine surveillance after repair of AAAD is recommended with closer attention to patients with recurrent or persistent pain.
Author Disclosures: K. M. Charlton-Ouw: Nothing to disclose; A. L. Estrera: Nothing to disclose; I. Jamshidy: Nothing to disclose; C. C. Miller: Nothing to disclose; A. Ray: Nothing to disclose; H. J. Safi: Nothing to disclose; H. K. Sandhu: Nothing to disclose; A. Tanaka: Nothing to disclose. 
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Prevalence of Myocardial Injury
